top of page
Browse by category
Search


MBS associated with favourable short‑ to mid‑term safety outcomes and improvements in weight and obesity‑related comorbidities in adolescents
Metabolic and bariatric surgery (MBS) can be delivered safely and effectively for adolescents and young adults living with severe obesity, offering promising improvements in weight loss and obesity-related health conditions, according to a study by researchers from LSU's Pennington Biomedical Research Center, FMOL Health | Our Lady of the Lake Regional Medical Center and Metamor Institute. The study examined outcomes from 76 patients ages 10–25 who underwent bariatric surgery


British Hernia Society publishes first BHS Registry Inaugural Annual Report
The British Hernia Society (BHS) has published the Inaugural Annual Report of its new national hernia registry, the BHS Registry, a milestone achievement that delivers the comprehensive data clinicians have called for. Utilising Dendrite Clinical Systems’ intuitive and robust ‘Intellect-Web Registry’ software, the BHS Registry allowed surgeons to collect, analyse, track and report procedural, treatment and outcomes data from 2,262 hernia repairs that were recorded across fiv


Medicare launches Bridge programme for GLP-1 coverage
For decades, it’s been against the law for Medicare to pay for weight-loss medication, but that changed on July 1, with the launch of a new programme called Bridge. It gives some people over 65, or who have Medicare for other reasons, access to some weight management medications if they meet certain weight and health criteria. Doctors who specialise in treating obesity, and study its impact on individuals and society, welcome this shift. The policy began in the previous presi


Introducing a new era in robotic vessel sealing
At the recent IFSO-EC meeting in Malaga, Spain, Medtronic hosted a fascinating lunch time symposium tiled, ‘A new era in robotic vessel sealing’ featured several presentations and a panel discussion on Medtronic's Ligasure vessel sealing technology, covering its technical underpinnings, clinical applications and recent integration into the Hugo RAS robotic surgery platform. Hugo RAS Ligasure Maryland In the first presentation by Dr Bruce Dunne, Senior Distinguished Engineer,


TABFAT trial: Tirzepatide may change how the body uses energy
Tirzepatide does not just help people lose weight, but it also activates brown adipose tissue, representing a major milestone in obesity research, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago. "In the TABFAT trial, we asked a different question: Beyond eating less, does tirzepatide also change how the body burns energy - specifically through brown adipose tissue, a metabolically active type of fat that produces heat and consum


POWER: The next chapter of obesity care
The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the US’ most pressing chronic diseases. A commentary published in Gastroenterology, "Revisiting POWER in the GLP-1 Age," updates the landmark POWER (Practice Guide on Obesity and Weight Management, Education, and Resources) framework first published in 2017. The figure provides a comprehensive, multidi


Long-term health care costs higher for GLP-1 vs MBS
Adults with obesity and diabetes face higher health care utilisation costs with GLP-1s treatment compared with Bariatric metabolic surgery (BMS), excluding intervention costs, largely reflecting differences in early clinical trajectories, according to a study by researchers from Israel. These findings suggest that, among patients eligible for both interventions, BMS may confer combined clinical and economic advantages over long-term follow-up. The study was designed to compar


RYGB and SG are cost-effective for adolescents with severe obesity
Both Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are cost-effective compared with no surgery for adolescents with severe obesity, according to a study by researchers from the Northwestern University Feinberg School of Medicine. Dr John B Rode from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined the ten-year cost effectiveness of metabolic and bariatric surgery for adolescents with severe obesity using published resul


Shimadzu Medical Systems launches release of the FLUOROspeed X1 edition ST
Shimadzu Medical Systems USA has launched the FLUOROspeed X1 edition ST, patient side conventional RF table system with a 665lb static patient weight capacity (500lb all motion weight capacity), for both bariatric and routine daily fluoroscopic and radiographic exams. According to the company, the X1 offers a cost-effective balance of functionality to support a wide range of general RF applications, such as chest, abdomen, or extremities along with Upper GI's, modified swallo


First commercial EndoZip ESG cases performed in France
The first commercial EndoZip Automated Suturing System for Endoscopic Sleeve Gastroplasty (ESG) cases have been performed in France. The cases were performed at the Institute of Image-Guided Surgery (IHU Strasbourg) in Strasbourg, France, under the leadership of Professor Silvana Perretta, Chief of Foregut Surgery and Advanced Gastrointestinal Endoscopy. This milestone represents another important step in Nitinotes' European commercial expansion following recent introductions
Browse by tag






bottom of page
